AKEBIA THERAPEUTICS, INC. (AKBA)
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOLID BIOSCIENCES INC. (SLDB)
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
INFLECTION POINT ACQUISITION CORP. IV (MRLN)
Merlin, Inc. To Participate in Upcoming Investor Conferences
CREDO TECHNOLOGY GROUP HOLDING LTD (CRDO)
Credo Technology Group Holding Ltd Reports Fourth Quarter and Fiscal Year 2026 Financial Results
ZETA GLOBAL HOLDINGS CORP. (ZETA)
Zeta Global Announces Olympic Gold Medalist, Entrepreneur and Founder Lindsey Vonn as Second Zeta Live 2026 Keynote Speaker
SONOS INC (SONO)
Sonos Announces Participation in Rosenblatt’s 6th Annual Technology Virtual Summit
CURBLINE PROPERTIES CORP. (CURB)
Curbline Properties Second Quarter 2026 Investment and Capital Markets Update
ABIVAX S.A. (ABVX)
Abivax annonce des résultats majeurs de l’essai de maintenance de phase 3 ABTECT évaluant l’obéfazimod dans le traitement de la rectocolite hémorragique active modérée à sévère
8X8 INC /DE/ (EGHT)
8x8, Inc. Announces Participation in Evercore Global TMT Conference
ABIVAX S.A. (ABVX)
Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis